Analgesics in Latvia
Analgesics is witnessing a growth surge in 2022 as pandemic-related restrictions are lifted and social/professional life shifts back to a more normal mode. A high proportion of analgesics are used to tackle seasonal colds and flu symptoms, which is normally seasonal and caused by more human interaction inside buildings during the winter season in Latvia. In 2021, analgesics had witnessed a slowdown in current value sales after a boom during 2020 when consumers stockpiled products. Lower sales oc...
Euromonitor International's Analgesics in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in Latvia
- Euromonitor International
- October 2022
- List Of Contents And Tables
- ANALGESICS IN LATVIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Analgesics back on track after COVID-19 pandemic related turmoil
- Nycomed Latvia holds lead in analgesics but is under pressure from cheaper brands
- Ibuprofen leads paediatric analgesics
- PROSPECTS AND OPPORTUNITIES
- Analgesics value sales to stagnate followed by a decline
- Ibuprofen and acetaminophen will remain top of the agenda when self-medicating
- Parents are more likely to upgrade to added-value analgesics
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2017-2022
- Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN LATVIA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook